Gerresheimer stock weighs stronger Q4 against margin pressure

Gerresheimer released preliminary third-quarter results on Friday, October 30, 2026, showing stronger revenue but continued pressure on earnings in parts of the portfolio. The company expects a stronger final quarter and remains within its full-year outlook, according to Gerresheimer.

Revenue growth meets uneven profitability

Revenue including business units currently in the sales process rose 8% year over year to EUR 605 million in the third quarter. Adjusted EBITDA reached EUR 103 million, compared with EUR 106 million in the adjusted prior-year quarter, leaving the quarterly result broadly stable.

For the first nine months, revenue was approximately EUR 1.7 billion, while adjusted EBITDA fell to EUR 272 million from EUR 331 million a year earlier. Gerresheimer cited inventory reductions and weaker performance in Tubular Glass Europe and Moulded Glass as key factors weighing on the nine-month comparison.

Drug delivery supports the outlook

Containment & Delivery Systems provided the strongest contribution to quarterly growth, while demand for drug delivery devices also supported the broader business. The company said all three segments contributed to the revenue increase.

Management expects further earnings improvement in the fourth quarter and continues to target its existing full-year ranges for revenue, adjusted EBITDA margin and free cash flow before mergers and acquisitions. The final third-quarter statement is scheduled for December 2026.

What changed since the last report

The real-time quote of Gerresheimer stock traded at EUR 31.17 on Lang & Schwarz at 18:03 CET on Thursday, November 5, 2026. The latest relevant own report had cited EUR 32.26 in premarket trading on Wednesday, November 4.

Germany's DAX market environment provides the broader setting for investors assessing the stock alongside the company's earnings outlook.

More news and analyses on Gerresheimer stock will follow the company's final quarterly disclosures.